J. Zwaveling

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis

Imke H. Bartelink, Arief Lalmohamed, Elisabeth M L van Reij et al. · The Lancet Haematology · 2016 · 279 citations · Full text

Haemopoietic Cell Transplantation, Busulfan Exposure, Transplantation +10

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Imke H. Bartelink, Robbert G. M. Bredius, Svetlana V. Belitser et al. · Biology of Blood and Marrow Transplantation · 2009 · 122 citations · Full text

Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric Patients

J. Zwaveling, Rogier R. Press, Robbert G. M. Bredius et al. · Therapeutic Drug Monitoring · 2008 · 84 citations

Presented Pediatric Population, Genetic Epidemiology, Immunology +16

Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation

Imke H. Bartelink, Robbert G. M. Bredius, Tessa T. Ververs et al. · Biology of Blood and Marrow Transplantation · 2007 · 83 citations · Full text

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity

J. Zwaveling, Robbert G. M. Bredius, S C L M Cremers et al. · Bone Marrow Transplantation · 2004 · 73 citations · Full text

Intravenous Busulfan, Transplantation, Early Clinical Outcome +8